Canada markets closed

Epigenomics AG (EPGNF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.65000.0000 (0.00%)
At close: 01:17PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in EUR. All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
447
485
6,203
842
1,125
Cost of Revenue
105
120
136
145
253
Gross Profit
342
365
6,067
697
872
Operating Expenses
Research Development
4,496
6,191
3,111
3,659
7,340
Selling General and Administrative
3,918
4,296
4,437
3,467
4,523
Total Operating Expenses
14,508
13,224
10,229
10,811
15,974
Operating Income or Loss
-14,166
-12,859
-4,162
-10,114
-15,102
Interest Expense
102
130
52
55
63
Income Before Tax
-16,368
-12,101
-2,410
-11,663
-14,566
Income Tax Expense
-77
-77
18
23
2,454
Income from Continuing Operations
-16,291
-12,024
-2,428
-11,686
-17,020
Net Income
-16,291
-12,024
-2,428
-11,686
-17,020
Net Income available to common shareholders
-16,291
-12,024
-2,428
-11,686
-17,020
Basic EPS
-
-2.96
-0.87
-8.08
-14.32
Diluted EPS
-
-2.96
-0.87
-8.08
-14.32
Basic Average Shares
-
4,067
2,802
1,445
1,188
Diluted Average Shares
-
4,067
2,802
1,445
1,188